1. Structural Biology and Molecular Biophysics
  2. Cell Biology
Download icon

Structures of TorsinA and its disease-mutant complexed with an activator reveal the molecular basis for primary dystonia

  1. F Esra Demircioglu
  2. Brian A Sosa
  3. Jessica Ingram
  4. Hidde L Ploegh
  5. Thomas U Schwartz  Is a corresponding author
  1. Massachusetts Institute of Technology, United States
  2. Whitehead Institute for Biomedical Research, United States
Research Article
  • Cited 36
  • Views 2,412
  • Annotations
Cite this article as: eLife 2016;5:e17983 doi: 10.7554/eLife.17983

Abstract

The most common cause of early onset primary dystonia, a neuromuscular disease, is a glutamate deletion (ΔE) at position 302/303 of TorsinA, a AAA+ ATPase that resides in the endoplasmic reticulum. While the function of TorsinA remains elusive, the ΔE mutation is known to diminish binding of two TorsinA ATPase activators: lamina-associated protein 1 (LAP1) and its paralog, luminal domain like LAP1 (LULL1). Using a nanobody as a crystallization chaperone, we obtained a 1.4 Å crystal structure of human TorsinA in complex with LULL1. This nanobody likewise stabilized the weakened TorsinAE-LULL1 interaction, which enabled us to solve its structure at 1.4 Å also. A comparison of these structures shows, in atomic detail, the subtle differences in activator interactions that separate the healthy from the diseased state. This information may provide a structural platform for drug development, as a small molecule that rescues TorsinAΔE could serve as a cure for primary dystonia.

Article and author information

Author details

  1. F Esra Demircioglu

    Department of Biology, Massachusetts Institute of Technology, Cambridge, United States
    Competing interests
    F Esra Demircioglu, Filed a provisional patent application protecting the use of the crystal structures (U.S.P.T.O. No. 62/330,683).
  2. Brian A Sosa

    Department of Biology, Massachusetts Institute of Technology, Cambridge, United States
    Competing interests
    Brian A Sosa, Filed a provisional patent application protecting the use of the crystal structures (U.S.P.T.O. No. 62/330,683).
  3. Jessica Ingram

    Whitehead Institute for Biomedical Research, Cambridge, United States
    Competing interests
    No competing interests declared.
  4. Hidde L Ploegh

    Whitehead Institute for Biomedical Research, Cambridge, United States
    Competing interests
    No competing interests declared.
  5. Thomas U Schwartz

    Department of Biology, Massachusetts Institute of Technology, Cambridge, United States
    For correspondence
    tus@mit.edu
    Competing interests
    Thomas U Schwartz, Filed a provisional patent application protecting the use of the crystal structures (U.S.P.T.O. No. 62/330,683).
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8012-1512

Funding

Dystonia Medical Research Foundation

  • Thomas U Schwartz

National Institutes of Health

  • Thomas U Schwartz

National Institutes of Health

  • Hidde L Ploegh

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Wesley I Sundquist, University of Utah, United States

Publication history

  1. Received: May 19, 2016
  2. Accepted: August 3, 2016
  3. Accepted Manuscript published: August 4, 2016 (version 1)
  4. Accepted Manuscript updated: August 17, 2016 (version 2)
  5. Version of Record published: August 25, 2016 (version 3)

Copyright

© 2016, Demircioglu et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,412
    Page views
  • 577
    Downloads
  • 36
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Further reading

    1. Neuroscience
    2. Structural Biology and Molecular Biophysics
    Jordana K Thibado et al.
    Research Article

    The metabotropic glutamate receptors (mGluRs) form a family of neuromodulatory G protein-coupled receptors that contain both a seven-helix transmembrane domain (TMD) and a large extracellular ligand-binding domain (LBD) which enables stable dimerization. While numerous studies have revealed variability across subtypes in the initial activation steps at the level of LBD dimers, an understanding of inter-TMD interaction and rearrangement remains limited. Here we use a combination of single molecule fluorescence, molecular dynamics, functional assays, and conformational sensors to reveal that distinct TMD assembly properties drive differences between mGluR subtypes. We uncover a variable region within transmembrane helix 4 (TM4) that contributes to homo- and heterodimerization in a subtype-specific manner and tunes orthosteric, allosteric and basal activation. We also confirm a critical role for a conserved inter-TM6 interface in stabilizing the active state during orthosteric or allosteric activation. Together this study shows that inter-TMD assembly and dynamic rearrangement drive mGluR function with distinct properties between subtypes.

    1. Microbiology and Infectious Disease
    2. Structural Biology and Molecular Biophysics
    Caillat Christophe et al.
    Research Article

    The HIV-1 gp120/gp41 trimer undergoes a series of conformational changes in order to catalyze gp41-induced fusion of viral and cellular membranes. Here, we present the crystal structure of gp41 locked in a fusion intermediate state by an MPER-specific neutralizing antibody. The structure illustrates the conformational plasticity of the six membrane anchors arranged asymmetrically with the fusion peptides and the transmembrane regions pointing into different directions. Hinge regions located adjacent to the fusion peptide and the transmembrane region facilitate the conformational flexibility that allows high affinity binding of broadly neutralizing anti-MPER antibodies. Molecular dynamics simulation of the MPER Ab-stabilized gp41 conformation reveals a possible transition pathway into the final post-fusion conformation with the central fusion peptides forming a hydrophobic core with flanking transmembrane regions. This suggests that MPER-specific broadly neutralizing antibodies can block final steps of refolding of the fusion peptide and the transmembrane region, which is required for completing membrane fusion.